Navigation Links
PharmAthene Completes Dosing in Valortim® Phase I Clinical Trial
Date:4/13/2011

ANNAPOLIS, Md., April 13, 2011 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: PIP) announced today that it has completed dosing in a U.S. Phase I clinical trial of its fully human anti-toxin monoclonal antibody, Valortim®, being developed for the prevention and treatment of inhalational anthrax.

The randomized, placebo-controlled, double-blind Phase I clinical trial was designed to evaluate single escalating doses of 1, 5, or 10 mg/kg of Valortim® (or placebo) administered intravenously over a 120 minute infusion period.  A total of 28 participants, all healthy male and female volunteers between the ages of 18 and 60 years, were enrolled in the study.

"We have completed dosing of all 28 subjects and are pleased to report that no infusion-related adverse reactions have been observed in the current Phase I trial.  We anticipate that safety follow-up will be completed in the third quarter of 2011 with final unblinded results available later in the year," remarked Dr. Thomas Fuerst, Executive Vice President and Chief Scientific Officer.

"This represents an important step in the development of Valortim®, which is being developed to meet the criteria for stockpiling in the U.S. Strategic National Stockpile," continued Dr. Fuerst.  "In preclinical animal studies Valortim® has been shown to protect both rabbits and monkeys against the lethal effects of anthrax infection when administered at the time of exposure, at doses as low as 1.0 mg/kg.  When administered to rabbits after the development of symptoms, Valortim® also improved survival as late as 48 hours post-exposure as compared to control animals.  We look forward to completing the Phase I clinical trial, which will provide important information about the IV dosing schedule for Valortim® in humans."  

The Valortim® project has been conducted with
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. PharmAthene to Webcast its Third Quarter Conference Call on November 13, 2007 at 4:30 P.M. Eastern Time
2. PharmAthenes Recombinant Butyrylcholinesterase (rBChE) May Play A Neuroprotective Role in Alzheimers Disease
3. PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop
4. PharmAthene Initiates Phase I Clinical Trial of Nerve Agent Bioscavenger Protexia(R)
5. PharmAthene to Host a Conference Call and Webcast on Wednesday, April 29th at 4:30 PM to Provide an Update on the SparVax(TM) rPA Anthrax Vaccine Program
6. PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA
7. PharmAthene Submits Proposal to BARDA in Response to Broad Agency Announcement for Advanced Research and Development for Valortim(R)
8. PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop
9. PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop
10. PharmAthene Develops Thermostable Lyophilized rPA Anthrax Vaccine Under a Challenge Grant From the National Institutes of Health
11. PharmAthene Presents New Data for Lyophilized rPA Anthrax Vaccine Showing Enhanced Immunogenicity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... July 28, 2015 Isis Pharmaceuticals, Inc. (NASDAQ: ... a live webcast on Tuesday, August 4 at 11:30 ... financial results and report on pipeline and business progress.  ... call by dialing 877-443-5662 or access the webcast at ... for a limited time at the same address. ...
(Date:7/28/2015)... SOUTH SAN FRANCISCO, Calif. , July 28, ... ) today announced that it will report its ... Tuesday, August 4, 2015.  Rigel senior management will ... and webcast at 4:30pm Eastern Time (1:30pm Pacific ... Participants can access the live conference call by ...
(Date:7/27/2015)... 2015 CTI BioPharma Corp. (NASDAQ and MTA: ... second quarter 2015 financial results on Thursday, August 6, ... Following the announcement, members of the management team will ... and provide a general corporate update at 4:30 p.m. ... be obtained as follows: Thursday, August 6 ...
Breaking Medicine Technology:Webcast Alert: Isis Pharmaceuticals' Second Quarter 2015 Financial Results Conference Call 2Webcast Alert: Isis Pharmaceuticals' Second Quarter 2015 Financial Results Conference Call 3Rigel Announces Conference Call and Webcast to Report Second Quarter 2015 Financial Results 2CTI BioPharma to Report Second Quarter 2015 Financial Results on August 6, 2015 2
... Aug. 18, 2011 A national analysis conducted ... North America, Inc., identified Columbus, Ohio, as one ... that have hypertension risk factors and complications. The ... of a larger Takeda-sponsored hypertension awareness program called ...
... 18, 2011 Reportlinker.com announces that a ... its catalogue: China ... http://www.reportlinker.com/p0590608/China-Contract-Research-Organization-CRO-Industry-Report-2010-2011.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Disc ... high R&D costs of new drugs worldwide, ...
Cached Medicine Technology:Columbus Included in Analysis of Top Hypertension Hot Spots in the United States 2Columbus Included in Analysis of Top Hypertension Hot Spots in the United States 3Columbus Included in Analysis of Top Hypertension Hot Spots in the United States 4China Contract Research Organization (CRO) Industry Report, 2010-2011 2China Contract Research Organization (CRO) Industry Report, 2010-2011 3China Contract Research Organization (CRO) Industry Report, 2010-2011 4China Contract Research Organization (CRO) Industry Report, 2010-2011 5
(Date:7/28/2015)... ... July 28, 2015 , ... A ... shipbreaking workers than they are in the general population. Surviving Mesothelioma has just ... now. , Researchers at Taiwan’s National Health Research Institutes and three Taiwanese ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... Fertility ... chosen as a “Top Doctor 2015” by Atlanta Magazine. In Atlanta Magazine's annual Top ... by hundreds of her esteemed colleagues and peers in the metro area as one ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... Breakdown of Mets' David Wright's Spinal Stenosis Injury" discussed baseball player David Wright’s ... stenosis is acquired lumbar stenosis, brought on by degenerative changes in the spine, ...
(Date:7/28/2015)... Mountain View, CA (PRWEB) , ... July 28, ... ... Organic Coconut Water line has won the 2015 NCW Eco-Excellence Award for the ... adult, child and pet lifestyle industries and elevate companies that stand out for ...
(Date:7/28/2015)... Myers, Florida (PRWEB) , ... July 28, 2015 ... ... Ltd., America's trusted source for identifying Top Doctors, has based its selection process ... are the most outstanding in their medical specialties, in any area of medicine ...
Breaking Medicine News(10 mins):Health News:New Findings Suggest Mesothelioma is Not the Only Cancer Threat for Shipbreakers, According to Surviving Mesothelioma 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 3Health News:Spine Surgeon Weighs in on Uncertain Future Baseball Career Future for David Wright 2Health News:Spine Surgeon Weighs in on Uncertain Future Baseball Career Future for David Wright 3Health News:Coco Libre Wins 2015 NCW Eco-Excellence Award 2Health News:Fort Myers Plastic Surgeon Recognized as One of the America’s “Top Doctors®” by Prestigious Castle Connolly Medical Ltd. for 5 Years in a Row 2Health News:Fort Myers Plastic Surgeon Recognized as One of the America’s “Top Doctors®” by Prestigious Castle Connolly Medical Ltd. for 5 Years in a Row 3
... Council for American Medical Innovation Host "Best and Brightest ... CEO of AstraZeneca, David Miller, President and CEO of ... Today in Chicago, the "Best and Brightest Forum on ... biotechnology and patient advocacy to address the importance of ...
... Portal offers expanded career and recruitment resources , ... ... an onTargetjobs company that powers online career centers of ... Cardiology Career Network to its leading, online employment portfolio., ...
... 15 MedTrust Online, LLC has incorporated the NexCura(R) ... , a free portal that provides information tools ... best treatment decisions for their patients."This collaboration is another ... for their patients," said Chris Yoo, Ph.D., president and ...
... LOS ANGELES, April 15 Over the past two ... Department of Aging along with contracted vendors and service ... a senior" by participating in a series of hands-on ... demonstrate the physical challenges facing the elderly. "The program ...
... the April 16 issue of the journal "Neuron," was conducted ... the Stanford University School of Medicine, who characterized their finding ... , ... (Vocus) April 15, 2009 -- ...
... Patrick J. Dugan is the new chief legal officer ... this capacity, Dugan will manage the internal legal staff ... has served as lead outside counsel to Medical Mutual,s ... firm, Squire Sanders. Among Dugan,s career accomplishments are his ...
Cached Medicine News:Health News:Chicago's Top Minds Join National Business and Health Leaders in Addressing Medical Innovation, Highlighting Policies Needed to Maintain U.S. Competitiveness in Medical Science and Discovery 2Health News:Chicago's Top Minds Join National Business and Health Leaders in Addressing Medical Innovation, Highlighting Policies Needed to Maintain U.S. Competitiveness in Medical Science and Discovery 3Health News:Chicago's Top Minds Join National Business and Health Leaders in Addressing Medical Innovation, Highlighting Policies Needed to Maintain U.S. Competitiveness in Medical Science and Discovery 4Health News:Cardiology Career Network Launches Within HEALTHeCAREERS Network 2Health News:MedTrust Online to Provide NexCura Cancer Profiler Tools from Thomson Reuters to Oncologists 2Health News:SCAN Health Plan Provides 'Senior Sensitivity Training' to City of Los Angeles Department of Aging and Network Service Providers 2Health News:SCAN Health Plan Provides 'Senior Sensitivity Training' to City of Los Angeles Department of Aging and Network Service Providers 3Health News:UCSF, Stanford Study Reveals Neural Networks Targeted in Brain Diseases 2Health News:UCSF, Stanford Study Reveals Neural Networks Targeted in Brain Diseases 3Health News:UCSF, Stanford Study Reveals Neural Networks Targeted in Brain Diseases 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: